Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -417,808 | -333,468 | -199,649 | -485,136 | -91,169 |
Depreciation Amortization | 209,435 | 140,087 | 69,260 | 123,383 | 67,488 |
Income taxes - deferred | 91,414 | 83,823 | 87,004 | -90,158 | -4,096 |
Accounts receivable | -19,407 | -16,573 | -11,717 | -21,091 | -16,450 |
Accounts payable and accrued liabilities | -11,115 | -4,741 | -11,989 | -87,995 | 6,584 |
Other Working Capital | -59,351 | -66,974 | -69,660 | -90,483 | 16,537 |
Other Operating Activity | 317,614 | 232,037 | 118,725 | 597,969 | 82,531 |
Operating Cash Flow | $110,782 | $34,191 | $-18,026 | $-53,511 | $61,425 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 10,901 | 10,901 | 50,000 | 2,496 | 0 |
PPE Investments | -41,013 | -25,913 | -13,259 | -26,042 | -17,387 |
Net Acquisitions | -75,944 | -56,336 | -55,921 | -567,429 | -159,663 |
Purchase Of Investment | 50,000 | 50,000 | N/A | N/A | 0 |
Other Investing Activity | 3,150 | 3,150 | 3,150 | 0 | 0 |
Investing Cash Flow | $-52,906 | $-18,198 | $-16,030 | $-590,975 | $-177,050 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | 1,091,659 | 1,000,000 |
Debt Repayment | -139 | N/A | -130 | -238,153 | -228,153 |
Common Stock Issued | 36,952 | 28,812 | 20,556 | 59,036 | 43,100 |
Common Stock Repurchased | N/A | -137 | N/A | N/A | N/A |
Other Financing Activity | -2,491 | 4,863 | 1,749 | -53,406 | -26,247 |
Financing Cash Flow | $34,322 | $33,538 | $22,175 | $859,136 | $788,700 |
Exchange Rate Effect | -1,694 | 869 | -1,339 | 4,321 | -129 |
Beginning Cash Position | 733,324 | 733,324 | 733,324 | 514,353 | 514,353 |
End Cash Position | 823,828 | 783,724 | 720,104 | 733,324 | 1,187,299 |
Net Cash Flow | $90,504 | $50,400 | $-13,220 | $218,971 | $672,946 |
Free Cash Flow | |||||
Operating Cash Flow | 110,782 | 34,191 | -18,026 | -53,511 | 61,425 |
Capital Expenditure | -41,013 | -25,913 | -13,259 | -26,042 | -17,387 |
Free Cash Flow | 69,769 | 8,278 | -31,285 | -79,553 | 44,038 |